Fibroblasts from the skin of people with systemic sclerosis (SSc) can get more energy from their powerhouses, the mitochondria,…
Margarida Maia, PhD
Margarida is a biochemist (University of Porto, Portugal) with a PhD in biomedical sciences (VIB and KULeuven, Belgium). Her main interest is science communication. She is also passionate about design and the dialogue between art and science.
At Bionews we’re committed to providing the most accurate, relevant, and up-to-date reporting for our patient communities. Our goal is to ensure that everyone has access to disease-specific information that is both trustworthy and easy to understand. You can read more about our editorial policy here.
Articles by Margarida Maia, PhD
Exposure to silica, a mineral used to make building materials, at work is associated with younger age at diagnosis, more…
A grant of more than $400,000 has been awarded to a researcher who is searching for new ways to treat…
A protein called LMCD1 is present at higher levels in the lungs of patients with interstitial lung disease (ILD)…
The active ingredient of EHP-101, a cannabidiol-derived medicine being developed by Emerald Health Pharmaceuticals (EHP), can set in motion…
A protein called Thy-1 is present at higher levels in the skin of patients with systemic sclerosis (SSc) than…
A ranked list of genes in the skin may provide a molecular barcode, or signature, for subtypes of systemic…
The immunosuppressant everolimus, carried aboard droplets of fat (liposomes) to lung cells may ease scarring and inflammation linked to…
Fewer than one in five scleroderma patients seek help from mental health services, an international study found. The patients…
The U.S. Food and Drug Administration (FDA) has cleared Thermo Fisher Scientific to market its blood tests for diagnosing…